Who is the new Chief Commercial Officer at Neumora?

Neumora named Kaya Pai Panandiker Chief Commercial Officer, announced January 22, 2024.

Which similar companies made leadership changes around the same time?

Compugen (January 22, 2024), Rezolute (January 24, 2024), Corcept (January 29, 2024) and YS Biopharma (February 14, 2024) also announced leadership changes within 45 days of Neumora.

Neumora Therapeutics Appoints Kaya Pai Panandiker as Chief Commercial Officer

PUBLIC · NMRAJan 22, 2024

Position

Chief Commercial Officer

Company

Neumora

Kaya Pai Panandiker

WatertownBiotechnologyHealth CareTherapeuticsBiotechnology Research

Description

Neumora Therapeutics, Inc. announces the appointment of Kaya Pai Panandiker as chief commercial officer and a member of Neumora’s executive team. Ms

Quick answer

Neumora Therapeutics Appoints Kaya Pai Panandiker as Chief Commercial Officer (January 22, 2024). Neumora is based in Watertown, Massachusetts, United States.

Who is the new Chief Commercial Officer at Neumora?: Neumora named Kaya Pai Panandiker Chief Commercial Officer, announced January 22, 2024.
What did Neumora announce on January 22, 2024?: Neumora Therapeutics, Inc. announces the appointment of Kaya Pai Panandiker as chief commercial officer and a member of Neumora’s executive team.
What does Neumora do?: Brain diseases collectively represent one of the greatest challenges of our generation, affecting upwards of 1.5 billion people.
Where is Neumora based?: Neumora is based in Watertown, Massachusetts, United States.
Which similar companies made leadership changes around the same time?: Compugen (January 22, 2024), Rezolute (January 24, 2024), Corcept (January 29, 2024) and YS Biopharma (February 14, 2024) also announced leadership changes within 45 days of Neumora.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biotechnology Research

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Compugen Welcomes Kara Rudy as Vice President, Marketing (January 22, 2024)
Rezolute Expands Leadership Team with Appointment of Daron Evans, MS, MBA, as Chief Financial Officer (January 24, 2024)
Corcept Appoints Roberto Vieira as President, Oncology (January 29, 2024)
YS Biopharma Announces Appointment of New Directors (February 14, 2024)
Paratus Sciences Appoints Theresa Heah, M.D., M.B.A. as Chief Executive Officer (February 21, 2024)
BPGbio Appoints Ritesh Srivastava as General Counsel (January 22, 2024)

Who to call at Neumora, and when

A new leader at Neumora brings new priorities and often new vendors. The first weeks are when they listen.

An alert the day Neumora raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Neumora, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Neumora. With Fundz connected, it knows.

Watch Fundz in

See plan options

Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Neumora

Location

260 Arsenal Place, Suite 1

Watertown, Massachusetts, United States

About

Brain diseases collectively represent one of the greatest challenges of our generation, affecting upwards of 1.5 billion people. However, treatments for many of the most prevalent brain disorders have been dominated by a single class of drugs, such as serotonin targeting antidepressants for MDD, leaving patients with a high degree of unmet medical need given the lack of diverse treatment options and mechanisms of action. We are taking a fundamentally different approach to the way treatments for brain diseases are developed. Our pipeline is comprised of programs pursuing therapeutically relevant targets implicated in Central Nervous System (CNS) diseases, each targeting a novel mechanism of action with best-in-class pharmacology. Our work is supported by our Precision Toolbox, which integrates a suite of translational, clinical, and computational tools to generate insights that can enable precision medicine approaches. Neumora is relentless in its commitment to discovering, developing and commercializing novel therapies for the 1.5 billion people living with brain diseases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Neumora changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Book a demo Explore plans